Analysts at StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a research report issued on Wednesday. The brokerage set a “sell” rating on the stock.
SenesTech Trading Down 2.1 %
Shares of NASDAQ SNES opened at $2.28 on Wednesday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 3.49 and a current ratio of 4.68. The business has a 50-day moving average of $3.15 and a 200-day moving average of $5.33. SenesTech has a fifty-two week low of $1.90 and a fifty-two week high of $53.28.
SenesTech (NASDAQ:SNES – Get Free Report) last posted its quarterly earnings results on Thursday, August 8th. The company reported ($3.08) earnings per share for the quarter, beating analysts’ consensus estimates of ($3.20) by $0.12. The firm had revenue of $0.46 million during the quarter, compared to the consensus estimate of $0.49 million. SenesTech had a negative return on equity of 168.64% and a negative net margin of 464.09%. During the same period last year, the company earned ($84.03) earnings per share. As a group, sell-side analysts anticipate that SenesTech will post -11 EPS for the current fiscal year.
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Articles
- Five stocks we like better than SenesTech
- What Are the FAANG Stocks and Are They Good Investments?
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- Consumer Staples Stocks, Explained
- AMD Gains Momentum With AI: Can It Beat Expectations?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.